Here’s what you should know:
1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.
2. Motus was attempting to offer 4.3 million shares initially, but reduced the scope of the offer ahead of the pricing. Motus is now selling 3.5 million shares. Motus had a price range between $5 and $7 per share in the IPO.
3. Motus is trading under the symbol MOTS.
More articles on supply chain:
Maine physician: Halting physician-aimed opioid marketing now is ’20 years’ too late
Somnia Anesthesia shakes up leadership team with new appointments — 3 insights
Survey says medical students learn the most about perioperative medicine by pairing anesthesiology with general surgery rotation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.